STOCK TITAN

Tempus AI SEC Filings

TEM NASDAQ

Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.

Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.

Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.

Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.

Rhea-AI Summary

Tempus AI, Inc. reported insider activity involving entities associated with CEO and Chairman Eric Lefkofsky. On May 27, 2026, Blue Media, LLC and Gray Media, LLC, entities managed by Lefkofsky, sold a combined 166,250 shares of Class A Common Stock in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2025.

Shares were sold at weighted-average prices within ranges disclosed around $45–$47 per share. After these sales, Blue Media, LLC held 15,620,748 shares and Gray Media, LLC held 8,832,851 shares of Tempus AI Class A Common Stock, in addition to other direct and indirect holdings reported for Lefkofsky and related foundations and entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
insider
-
Rhea-AI Summary

Tempus AI, Inc. reported insider activity involving entities associated with CEO and Chairman Eric Lefkofsky. On May 27, 2026, Blue Media, LLC and Gray Media, LLC, entities managed by Lefkofsky, sold a combined 166,250 shares of Class A Common Stock in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2025.

Shares were sold at weighted-average prices within ranges disclosed around $45–$47 per share. After these sales, Blue Media, LLC held 15,620,748 shares and Gray Media, LLC held 8,832,851 shares of Tempus AI Class A Common Stock, in addition to other direct and indirect holdings reported for Lefkofsky and related foundations and entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
insider
-
Rhea-AI Summary

Tempus AI, Inc. reports resale notices for Class A Common stock under Rule 144 documenting insider/affiliate sales.

The filings list sales including 22,335 shares by Eric Lefkofsky on 05/19/2026 for $984,303.45, 133,000 shares by Blue Media, LLC on 03/26/2026 for $6,169,148.87 and another 133,000 shares on 04/28/2026 for $6,800,899.01. Additional sales by affiliated entities show proceeds and dates as listed in the notice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
other
Rhea-AI Summary

Belcher Eric D reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Eric D. Belcher reported an equity compensation grant and his updated shareholdings. He received a grant of 5,913 shares of Class A common stock in the form of restricted stock units at a price of $0.00 per share. These RSUs vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if his board service ends at that meeting) or on May 21, 2027, subject to his continuous service. Following the grant, he holds 21,424 Class A shares directly and 14,033 shares indirectly through Nob Hill Ventures LLC, where he has sole investment control and economic interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
-
Rhea-AI Summary

West Nadja reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI director Nadja West received a grant of 5,913 Class A common shares in the form of restricted stock units. This is a compensation-related award with no cash paid by West, and it increases her direct holdings to 37,981 shares after the grant.

The RSUs will vest in full on the earlier of the company’s 2027 annual meeting of stockholders (or immediately before that meeting if her board service ends then) or on May 21, 2027. Vesting is conditioned on her continuous service with Tempus AI through the applicable vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
-
Rhea-AI Summary

Leonsis Theodore reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Theodore Leonsis reported an equity compensation grant and his current share holdings. He received an award of 5,913 shares of Class A Common Stock in the form of restricted stock units at a stated price of $0.00 per share, increasing his direct holdings to 21,424 shares. The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continued service as a director. In addition, an indirect position of 66,756 Class A Common Stock shares is reported as held by the Theodore J. Leonsis Revocable Trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
Rhea-AI Summary

Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Scott Gottlieb reported receiving an equity award of 5,913 shares of Class A common stock in the form of restricted stock units. These RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continuous service. Following this grant, he holds 40,749 shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
-
Rhea-AI Summary

Frederick Wayne A.I. reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Frederick Wayne A.I. received an award of 5,913 shares of Class A Common Stock in the form of restricted stock units. These RSUs carry no purchase price and will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, if he remains in continuous service. Following this equity award, his direct holdings reported in this filing total 30,749 shares of Class A Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
-
Rhea-AI Summary

Epstein David R reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI director David R. Epstein received an award of 5,913 shares of Class A common stock in the form of restricted stock units. The award was granted at no cash cost per share and increased his directly held position to 31,714 shares.

The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if his board service ends then) or on May 21, 2027, assuming he continues serving the company through the vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
Rhea-AI Summary

Doudna Jennifer A reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Jennifer A. Doudna reported receiving an equity compensation grant in the form of 5,913 shares of Class A common stock as a restricted stock unit (RSU) award. The filing shows she now holds 28,615 shares directly after this grant.

The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if her board service ends then) or on May 21, 2027, provided she continues serving as a director through the applicable vesting date. This is a routine, non-cash director compensation award rather than an open-market share purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider
-
Rhea-AI Summary

BARRIS PETER J reported acquisition or exercise transactions in this Form 4 filing.

Tempus AI, Inc. director Peter J. Barris received an equity award equivalent to 5,913 shares of Class A Common Stock in the form of restricted stock units. These RSUs will vest in full on the earlier of the company’s 2027 annual stockholders meeting or May 21, 2027, if he remains in continuous service. Following this grant, he directly holds 121,424 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
insider

FAQ

How many Tempus AI (TEM) SEC filings are available on StockTitan?

StockTitan tracks 133 SEC filings for Tempus AI (TEM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Tempus AI (TEM)?

The most recent SEC filing for Tempus AI (TEM) was filed on May 29, 2026.